Mankind Pharma

Mankind Pharma is an Indian multinational pharmaceutical company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.[4]

Mankind Pharma
TypePrivate
IndustryPharmaceutical
Founded1991 (1991)
Founders
Headquarters
Okhla Phase III, Delhi
,
India[2]
Area served
Worldwide
Key people
Products
RevenueIncrease ₹7,781 crore (US$970 million) (FY22)[3]
Increase ₹1,452 crore (US$180 million) (FY22)[3]
Number of employees
19,000+ (2022)
Websitewww.mankindpharma.com

Mankind Pharma is reportedly among India's top five pharmaceutical companies by domestic sales[5] and top two prescription drug companies by volumes.[6][7] Mankind Pharma's Manforce is the largest condom brand in India by market share,[8] while Prega News is the largest selling pregnancy test kit.[9]

History

Mankind Pharma came into existence in 1991, when it was formed into a legal corporation. Mankind Pharma actively started its operations in 1995, with the contributions of two brothers, Ramesh C. Juneja and Rajeev Juneja, who established the company with a seed capital of ₹50 lakh.[10] The company was started with 20 employees and launched in two states in the first year of its operation.[11]

Prega News livery on a SpiceJet aircraft.

The company acquired Magnet Labs Pvt. Ltd. to enter the antipsychotic segment in 2007.[12] Also it acquired Longifene-an appetite stimulant for children in January 2010 which was earlier a brand of UCB.[13]

In 2019, Mankind became the first Indian company and second only in the world to develop and launch Dydrogesterone, a drug used in high-risk pregnancies and infertility by the brand name Dydroboon.[14]

In 2022, Mankind acquired Panacea Biotec Pharma's domestic formulations brands in India and Nepal for ₹1,872 crore (US$230 million).[15] It then acquired a respiratory treatment product and an infant skincare brand from Dr. Reddy's Laboratories.[16] It also bought a majority stake in the Ayurvedic and herbal products manufacturer, Upakarma Ayurveda.[3]

In 2022, the company entered agritech[17] and pet care segments.[18]

See also

References
  1. Bhalla, Mohit; Rajagopal, Divya. "Mankind Pharma: The story of Juneja siblings, the biggest disruptors in Indian pharma space". The Economic Times. Retrieved 21 December 2022.
  2. Singh, Khomba. "Mankind Pharma's pocket-friendly pricing in demand". The Economic Times. Retrieved 21 December 2022.
  3. Mahtta, Priyal (28 November 2022). "Mankind Pharma acquires majority stake in Upakarma Ayurveda". mint. Retrieved 3 December 2022.
  4. "India's Mankind Pharma wants deals, sees FY domestic sales topping $700 mln". Reuters. 10 April 2015. Retrieved 21 March 2023.
  5. Singh, Raveena (20 March 2023). "At $6-7B, Mankind Pharma eyes Torrent's valuation. But its catch lies in Eris & Gland IPOs". The Ken. Retrieved 21 March 2023.
  6. "Sun Pharma becomes top company in prescriptions; topples Mankind Pharma". Times Now. Retrieved 22 November 2022.
  7. "Mankind Tops Indian Market By Prescription Volumes". The Pink Sheet Daily. Retrieved 21 December 2022.
  8. Tandon, Suneera (18 February 2022). "Durex becomes second-largest condom brand in India: Reckitt". Mint. Retrieved 22 November 2022.
  9. "Behind Mankind's plans to take Prega News to rural markets". Moneycontrol. Retrieved 22 November 2022.
  10. Hussain, Shabana (8 May 2014). "Mankind Pharma: Formulating Strategy To Enter The Big League". Retrieved 27 June 2018.
  11. "A Giant Leap For Mankind". Business Outlook India. 24 December 2011. Archived from the original on 29 June 2012. Retrieved 5 February 2013.
  12. Acquisition of Magnet Labs
  13. Mankind Pharma markets Longifene- 29 August 2011
  14. "Mankind Pharma launches drug for the treatment of infertility in India". The Economic Times. Retrieved 22 November 2022.
  15. "Mankind Pharma acquires Panacea's domestic formulation brands for Rs 1,872 cr". Business Today. 1 March 2022. Retrieved 22 November 2022.
  16. "Mankind Pharma acquires two derma and respiratory brands from Dr. Reddy's". Business Standard. Retrieved 22 November 2022.
  17. "Mankind Pharma forays into agri-tech space, plans to invest Rs 200 crore". Business Standard. 5 April 2022. Retrieved 1 March 2023.
  18. Pilla, Viswanath (21 December 2022). "Mankind Pharma enters pet care segment with launch PetStar brand". The Economic Times. Retrieved 1 March 2023.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.